These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16563524)
1. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. Overeem S; Verschuuren JJ; Fronczek R; Schreurs L; den Hertog H; Hegeman-Kleinn IM; van Duinen SG; Unmehopa UA; Swaab DF; Lammers GJ J Neuroimmunol; 2006 May; 174(1-2):187-91. PubMed ID: 16563524 [TBL] [Abstract][Full Text] [Related]
2. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons. Knudsen S; Mikkelsen JD; Jennum P Neuroreport; 2007 Jan; 18(1):77-9. PubMed ID: 17259865 [TBL] [Abstract][Full Text] [Related]
3. Reduced hypothalamic gray matter in narcolepsy with cataplexy. Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022 [TBL] [Abstract][Full Text] [Related]
4. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Fontana A; Gast H; Reith W; Recher M; Birchler T; Bassetti CL Brain; 2010 May; 133(Pt 5):1300-11. PubMed ID: 20403960 [TBL] [Abstract][Full Text] [Related]
5. The hypocretin neuron system: an arousal system in the human brain. Moore RY; Abrahamson EA; Van Den Pol A Arch Ital Biol; 2001 Apr; 139(3):195-205. PubMed ID: 11330201 [TBL] [Abstract][Full Text] [Related]
6. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Baumann CR; Bassetti CL Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination. van der Heide A; Hegeman-Kleinn IM; Peeters E; Lammers GJ; Fronczek R J Neuroimmunol; 2015 Jun; 283():58-62. PubMed ID: 26004157 [TBL] [Abstract][Full Text] [Related]
9. Voxel-based morphometry in hypocretin-deficient narcolepsy. Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731 [TBL] [Abstract][Full Text] [Related]
10. Narcolepsy and the hypocretins. Wurtman RJ Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425 [TBL] [Abstract][Full Text] [Related]
11. Hypocretin/orexin-containing neurons are produced in one sharp peak in the developing ventral diencephalon. Amiot C; Brischoux F; Colard C; La Roche A; Fellmann D; Risold PY Eur J Neurosci; 2005 Jul; 22(2):531-4. PubMed ID: 16045506 [TBL] [Abstract][Full Text] [Related]
12. Type II glucocorticoid receptor involvement in habituated activation of lateral hypothalamic area orexin-A-immunopositive neurons during recurring insulin-induced hypoglycemia. Kale AY; Paranjape SA; Briski KP Neurosci Res; 2006 Nov; 56(3):309-13. PubMed ID: 16997409 [TBL] [Abstract][Full Text] [Related]
13. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770 [TBL] [Abstract][Full Text] [Related]
14. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197 [TBL] [Abstract][Full Text] [Related]
15. Immobilization induced fos expression in the medial and lateral hypothalamic areas: a limited response of hypocretin neurons. Kiss A Ideggyogy Sz; 2007 Mar; 60(3-4):192-5. PubMed ID: 17451067 [TBL] [Abstract][Full Text] [Related]